ReachMD
Oncology and HematologyEpisodes
Episodes of Oncology and Hematology
Mark All
Search Episodes...
Host: Cem Akin, MD, PhD Guest: Daniel J. DeAngelo, MD, PhD Guest: Matthew J. Hamilton, MD Patients with indolent systemic mastocytosis frequently report a symptom burden disproportionate to measurable disease burden. Anti-
Host: Cem Akin, MD, PhD Guest: Daniel J. DeAngelo, MD, PhD New tyrosine kinase inhibitor (TKI) treatment options can significantly reduce symptom burden in patients with moderate to severe indolent systemic mastocytosis (ISM).
Host: Jeffrey V. Matous, MD Guest: Donna Catamero, NP Guest: Ajai Chari, MD GPRC5D-directed therapy is associated with impressive overall response rates and substantially positive clinical outcomes in heavily pretreated re
Host: Meghan Mooradian, MD This Patient Clinician Connection CME activity, led by Dr. Meghan Mooradian, focuses on the use of adjuvant immunotherapy in early-stage melanoma. The activity aims to educate clinicians on the role of i
Host: Caitlin Costello, MD Guest: Sagar Lonial, MD, FACP Bispecific antibodies are the newest immunotherapies approved for heavily pretreated relapsed/refractory myeloma, and they are shown to double response rates. Are you re
Host: David J. Kuter, MD, DPhil Guest: Spero R. Cataland, MD Guest: Catherine Broome, MD Guest: Cindy Neunert, MD, MSCS Because immune-mediated rare blood disorders are uncommon, healthcare providers often lack the kno
Host: Caitlin Costello, MD Guest: Sagar Lonial, MD, FACP Dive into the cutting-edge realm of bispecific antibodies for relapsed/refractory multiple myeloma with our experts, Dr. Caitlin Costello and Dr. Sagar Lonial. They expl
Host: Helena Yu, MD Dr. Helena Yu of Memorial Sloan Kettering Cancer Center presents an insightful overview of HER2 targeted therapy in non-small cell lung cancer (NSCLC), emphasizing the critical role of broad molecular profiling
Host: Benjamin Levy, MD Guest: Alexander Spira, MD, PhD, FACP Drs. Benjamin Levy and Alex Spira discuss the emerging role of TROP2 as a therapeutic target in non-small cell lung cancer (NSCLC) on ReachMD. They delve into the m
Host: Jyoti Patel, MD Guest: Pasi Antero Jänne, MD, PhD Dive into the forefront of precision oncology with Drs. Pasi Janne and Jyoti Patel, where they unravel the potential of HER3-directed antibody-drug conjugates (ADCs) in r
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Charu Aggarwal, MD, MPH Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understandin
Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understanding of the limitations existing agen
Host: Sagar Lonial, MD, FACP "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily p
Host: Charu Aggarwal, MD, MPH This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understanding of the limitations existing a
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodie
Host: Charu Aggarwal, MD, MPH Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understandin
Host: Charu Aggarwal, MD, MPH Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understandin
Host: Charu Aggarwal, MD, MPH Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understandin
Host: Charu Aggarwal, MD, MPH This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understanding of the limitations existing a
Host: Alexander Drilon, MD This program aims to raise awareness of approved and emerging targeted therapies and practice guidelines for ROS1+ NSCLC. It is critical to create a greater understanding of the limitations existing agen
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us